Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Revenue

Beijing Tiantan Biological Products had revenue of 1.79B CNY in the quarter ending June 30, 2025, with 10.70% growth. This brings the company's revenue in the last twelve months to 6.30B, up 18.20% year-over-year. In the year 2024, Beijing Tiantan Biological Products had annual revenue of 6.03B with 16.44% growth.

• Revenue (ttm): 6.30B
• Revenue Growth: +18.20%
• P/S Ratio: 6.36
• Revenue / Employee: 1.19M
• Employees: 5,298
• Market Cap: 40.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.03B	851.42M	16.44%
Dec 31, 2023	5.18B	919.14M	21.57%
Dec 31, 2022	4.26B	149.15M	3.63%
Dec 31, 2021	4.11B	666.56M	19.35%
Dec 31, 2020	3.45B	163.74M	4.99%